RM

Rohan Madhukar Bendre

Active Director Director DIN 08045151
DIN 08045151 First appointment Jan 2018 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Rohan Madhukar Bendre

Data last updated:

Rohan Madhukar Bendre is a Director at Arvontech Surgical Private Limited (since 2018). The company operates in Business Services.

DIN 08045151
Primary Designation Director
Industry Business Services
First Appointment 18 Jan 2018
Oldest Company Age 8 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arvontech Surgical Private Limited U74993PN2018PTC174447
Director18 Jan 20182018Active

Board colleagues of Rohan Madhukar Bendre

NameDINCompanyDesignation
Ankit Gopi Bhilare08045150Arvontech Surgical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Arvontech Surgical Private Limited
Premium access

Shareholding and investment profile for Rohan Madhukar Bendre

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rohan Madhukar Bendre

Rohan Madhukar Bendre currently holds 1 directorship: Arvontech Surgical Private Limited (Director, since 18 Jan 2018).

Rohan Madhukar Bendre was first appointed on 18 Jan 2018 as Director at Arvontech Surgical Private Limited.

The current boards of Rohan Madhukar Bendre's companies include Ankit Gopi Bhilare (Arvontech Surgical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available